Abbott Laboratories (ABT) Treasury Shares (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Treasury Shares data on file, last reported at $16.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 1.94% year-over-year to $16.9 billion; the trailing twelve-month figure through Mar 2026 stood at $16.9 billion (up 1.94% YoY), and the FY2025 full-year result was $17.2 billion, up 1.98% from the prior year.
• Treasury Shares declined to $16.9 billion in Q1 2026, from $17.2 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $260.2 million in Q4 2025 to a low of $234.5 million in Q2 2022.
• A 5-year average of $251.1 million and a median of $251.8 million in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 39.42% in 2022 and increased 0.24% in 2024, its largest moves.
• Tracing ABT's Treasury Shares over 5 years: stood at $15.2 billion in 2022, then gained by 4.94% to $16.0 billion in 2023, then grew by 5.4% to $16.8 billion in 2024, then gained by 1.98% to $17.2 billion in 2025, then dropped by 1.41% to $16.9 billion in 2026.
• Business Quant data shows ABT's Treasury Shares at $16.9 billion in Q1 2026, $17.2 billion in Q4 2025, and $16.9 billion in Q3 2025.